Panbela Therapeutics, Inc.

PBLA · OTC
Analyze with AI
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Activities
Net Income-$25-$35-$10-$5
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0-$0
Stock-Based Comp.$1$1$1$1
Change in WC-$1$1$2-$0
Other Non-Cash-$0$18$0-$0
Operating Cash Flow-$25-$15-$7-$4
Investing Activities
PP&E Inv.$0-$1$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0-$1$0
Investing Cash Flow$0-$1-$1$0
Financing Activities
Debt Repay.-$2$0$0-$1
Stock Issued$23$5$9$11
Stock Repurch.-$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$5$0$1$0
Financing Cash Flow$26$5$10$10
Forex Effect$0-$0-$0-$0
Net Chg. in Cash$1-$11$3$7
Supplemental Information
Beg. Cash$1$12$9$2
End Cash$3$1$12$9
Free Cash Flow-$25-$16-$7-$4
Panbela Therapeutics, Inc. (PBLA) Financial Statements & Key Stats | AlphaPilot